Joanne McCudden joins Domainex

Domainex Ltd has appointed Dr Joanne McCudden as Head of Business Development. Joanne has a wealth of experience in the biotech sector having held business development positions at Cobra
Biomanufacturing PLC and, more recently, with SynCo Bio Partners where she was the Director of Sales and Marketing.

Dr McCudden, commented “Domainex offers high-quality, added-value, drug discovery services to the global biotechnology and pharma marketplaces. Its technical expertise is superb; shown by the success realised on behalf of its clients and with its own internal drug research portfolio I am very pleased to join Domainex, especially at this exciting time of growth. It is a pivotal moment for the business, and I look forward to helping to expand its client base, whilst supporting the outlicensing effort for the internal programmes.”

Dr Eddy Littler, CEO of Domainex, said: “Domainex is entering a new phase in its development. Our service division is undergoing a significant expansion with a number of new contracts, and our drug
discovery division has advanced its first project - on the kinase targets IKKe and TBK1 - to a point where we will seek to outlicense the project during 2011. We are delighted that Joanne is joining Domainex in order to spearhead our future Business Development activities.”